Catalyst Wire Dossier Catalyst Wire Dossier

Harvoni 90/400 mg

sofosbuvir/ledipasvir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Harvoni 90/400 mg, covering 2016-12-29 to 2016-12-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA) [Phase 1]

See pricing